华虹半导体(01347)发布公告，以下变动自2025年10月31日起生效：白鹏，本公司执行董事及总裁，获 委任为本公司董事会主席、提名委员会主席及授权代表;唐均君辞任本公司执行董事、董事会主席及提 名委员会主席。唐均君亦不再担任本公司授权代表。 ...

格隆汇10月31日丨华虹半导体(01347.HK)发布公告，以下变动自2025年10月31日起生效：白鹏，公司执 行董事及总裁，获委任为公司董事会主席、提名委员会主席及授权代表；唐均君辞任公司执行董事、董 事会主席及提名委员会主席，亦不再担任公司授权代表。 ...

智通财经APP讯，华虹半导体(01347)发布公告，以下变动自2025年10月31日起生效：白鹏，本公司执行 董事及总裁，获委任为本公司董事会主席、提名委员会主席及授权代表;唐均君辞任本公司执行董事、 董事会主席及提名委员会主席。唐均君亦不再担任本公司授权代表。 ...

Core Points - The Hang Seng Index closed at 25,906.65 points, down 1.43% [1] - The Hang Seng Tech Index closed at 5,908.08 points, down 2.37% [1] Company Performance - Semiconductor stocks led the decline, with Hua Hong Semiconductor falling over 7% and SMIC down over 5% [1] - Major tech stocks also experienced losses, with Alibaba down over 4%, Tencent Holdings down over 3%, and JD Group and Baidu Group both down over 2% [1] Sector Performance - The pharmaceutical and biotechnology sector saw gains, with Innovent Biologics rising over 7%, and Fosun Pharma and Rongchang Biologics both increasing over 6% [1]

獨立非執行董事： 張祖同 王桂壎太平紳士 封松林 HUA HONG SEMICONDUCTOR LIMITED 華虹半導體有限公司 董事名單與其角色和職能 華虹半導體有限公司董事會（「董事會」）成員載列如下： 執行董事： 白鵬 （董事會主席及總裁） 非執行董事： 葉峻 孫國棟 陳博 熊承艷 董事會設立三個委員會。下表提供各董事會成員在該等委員會中所擔任的職位： | | | 委員會成員 | | | --- | --- | --- | --- | | 董事 | 提名 | 薪酬 | 審核 | | 白鵬 | C | | | | 葉峻 | | M | | | 孫國棟 | | | | | 陳博 | | | | | 熊承艷 | | | M | | 張祖同 | | | C | | 王桂壎太平紳士 | M | C | | | 封松林 | M | M | M | 附註： C 有關董事委員會主席 M 有關董事委員會成員 二零二五年十月三十一日 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 HUA HONG SEMICONDUCTOR LIMITED 華虹半導體有限公司 （於香港註冊成立之有限公司） （股份代號：01347） 辭任執行董事、變更董事會主席 變更提名委員會成員及變更授權代表 本公告乃根據香港聯合交易所有限公司（「聯交所」）證券上市規則（「上市規則」） 第13.51(2)條而作出。 華虹半導體有限公司（「本公司」）董事會（「董事會」）欣然宣佈，以下變動自二零 二五年十月三十一日起生效： 委任董事會主席、提名委員會主席及授權代表 董事會宣佈，鑒於下文披露的唐先生的辭任，本公司執行董事及本公司總裁白先 生獲委任為本公司董事會主席、提名委員會主席及授權代表，自二零二五年十月 三十一日起生效，並仍留任本公司總裁。董事會認為，鑒於白先生在半導體行業 擁有深厚的專業經驗，由白先生同時擔任董事會主席及本公司總裁之職務，將有 利於本集團的管理。董事會亦相信，董事會主席與總裁職務合二為一，有助於 ...

港股芯片股走低，华虹半导体跌超5%，中芯国际跌超4%，上海复旦跌超3%，英诺赛科跌超2%。 ...

Core Viewpoint - The Hong Kong stock market is experiencing a downturn, with the Hang Seng Technology Index declining significantly, while innovative pharmaceutical stocks are performing well amidst a broader market weakness [1][2]. Group 1: Market Performance - On October 31, the three major indices in Hong Kong fell, with the Hang Seng Technology Index seeing an afternoon drop of 2% [1]. - Technology stocks broadly declined, while innovative pharmaceutical stocks rose against the trend [1]. - The semiconductor sector weakened, with major stocks like Hua Hong Semiconductor and SMIC experiencing significant declines of over 7% and 5%, respectively [1]. Group 2: Economic Outlook - According to recent research from China Merchants Securities, the combination of the Federal Reserve's interest rate cuts and an unexpected end to balance sheet reduction is favorable for global risk assets [1]. - Despite hawkish comments from Powell increasing uncertainty around the rate cut path, the trend towards easing is clear, suggesting that current market dips may present buying opportunities [1]. - The institution anticipates a 25 basis point rate cut in December and three additional cuts in the following year, which is more aggressive than market expectations [1]. Group 3: Investment Recommendations - The institution believes that the dual easing policies from the US and China will benefit risk assets, with Hong Kong stocks expected to enter a "slow bull" market due to strong foreign capital inflows [2]. - The Hang Seng Technology Index ETF is currently valued at 23.50 times earnings, which is approximately 32.84% below historical averages, indicating a safety margin for investors [2]. - The report suggests focusing on leading internet technology companies, high-end manufacturing related to AI, AI-related power sectors, and selectively investing in innovative pharmaceutical stocks [2].

Group 1 - The Hong Kong stock market experienced a decline on October 31, with the Hang Seng Technology Index dropping over 1.5% in the afternoon session, driven by widespread losses in tech stocks and weakness in the semiconductor sector [1] - The Hang Seng Technology Index ETF (513180) followed the index's downward trend, with leading stocks such as Kingdee International, Kingsoft, and Haier Smart Home performing well, while stocks like Hua Hong Semiconductor, SMIC, BYD, Alibaba, Kuaishou, and Tencent Holdings faced significant declines, with Hua Hong Semiconductor dropping over 7% in the afternoon [1] - According to Huaxi Securities, the global market is currently in a "vacuum period" following the US-China leaders' meeting, and the market is under pressure due to the lack of decisions from the Federal Reserve regarding the December meeting, alongside a strengthening US dollar [1] Group 2 - The Hang Seng Technology Index has seen a moderate increase of 37.49% since April 8, which is comparable to the 37.85% increase of the Wind All A Index, despite a significant pullback in October [1] - The current valuation of the Hang Seng Technology Index ETF (513180) is at 23.50 times P/E ratio, which is at a valuation percentile of approximately 32.84%, indicating that it is lower than 70% of its historical valuation period, suggesting a certain margin of safety for investors [2] - Investors without a Hong Kong Stock Connect account may consider using the Hang Seng Technology Index ETF (513180) to gain exposure to core AI assets in China [2]

Core Viewpoint - The Hang Seng Index closed at 26,050.08 points, down 0.89%, while the Hang Seng Tech Index fell by 1.91% to 5,936.39 points, indicating a bearish trend in the market [1] Group 1: Market Performance - The Hang Seng Index experienced a decline of 0.89% [1] - The Hang Seng Tech Index saw a decrease of 1.91% [1] Group 2: Sector Performance - Innovative drug concept stocks showed strong performance, with 3SBio rising over 10% and Innovent Biologics increasing nearly 7% [1] - Chip stocks generally fell, with Hua Hong Semiconductor dropping nearly 7%, SMIC declining over 5%, and Shanghai Fudan decreasing nearly 5% [1]